RXRX vs UNH · rev $14.1M vs P/E 30, rev $112.03B
Recursion Pharmaceuticals Inc (RXRX) versus UnitedHealth Group Incorporated (UNH) — a side-by-side from cached financials, not a winner call.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
UnitedHealth Group Incorporated (UNH) is a healthcare plans company listed on NYSE. It is led by Stephen J. Hemsley.
Latest reported RXRX revenue for 2026-06-30 was $14.1M. Net income was -$248.5M. RXRX currently screens at market cap $1.75B.
Latest reported UNH revenue for 2026-06-30 was $112.03B. Net income was $5.48B. Revenue was up 0.3% from 2026-03-31 to 2026-06-30. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
RXRX currently screens at market cap $1.75B. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
Not investment advice. Open the RXRX and UNH stock pages for the full models.
Not investment advice.